1 Introduction 10
1.1 Industry Definition and Research Scope 10
1.1.1 Industry Definition 10
1.1.2 Research Scope 11
1.2 Research Methodology 14
1.2.1 Overview of Market Research Methodology 14
1.2.2 Market Assumption 15
1.2.3 Secondary Data 15
1.2.4 Primary Data 15
1.2.5 Data Filtration and Model Design 17
1.2.6 Market Size/Share Estimation 18
1.2.7 Research Limitations 19
1.3 Executive Summary 20
2 Market Overview and Dynamics 23
2.1 Market Size and Forecast 23
2.1.1 Impact of COVID-19 on the Market 28
2.2 Major Growth Drivers 30
2.3 Market Restraints and Challenges 35
2.4 Emerging Opportunities and Market Trends 40
2.5 Porters Fiver Forces Analysis 44
3 Segmentation of Global Market by System Component 48
3.1 Market Overview by System Component 48
3.2 Data Collection Tools 50
3.2.1 Digital Platforms 52
3.2.2 Mobile Apps 53
3.2.3 Desktop-based Software 54
3.2.4 Wearables 55
3.2.5 Biosensors 56
3.3 Data Integration Systems 57
4 Segmentation of Global Market by Therapeutic Area 58
4.1 Market Overview by Therapeutic Area 58
4.2 Cardiovascular Diseases 60
4.3 Neurodegenerative Disorders 61
4.3.1 Parkinsons Disease 63
4.3.2 Multiple Sclerosis 64
4.3.3 Alzheimers Disease 65
4.4 Sleep and Movement Diseases 66
4.5 Psychiatric Disorders 67
4.6 Chronic Pain 68
4.7 Gastrointestinal Diseases 69
4.8 Diabetes 70
4.9 Respiratory Conditions 71
4.10 Other Diseases 72
5 Segmentation of Global Market by Application 73
5.1 Market Overview by Application 73
5.2 Wellness 75
5.3 Disease Diagnosis 76
5.4 Personalised Medication 77
5.5 Drug Discovery and Development 78
6 Segmentation of Global Market by Development Status 80
6.1 Market Overview by Development Status 80
6.2 Novel Digital Biomarkers 83
6.3 Original Digital Biomarkers 84
6.4 Approved Digital Biomarkers 85
7 Segmentation of Global Market by End User 86
7.1 Market Overview by End User 86
7.2 Biopharmaceutical Companies & Labs 88
7.3 Healthcare Providers 89
7.4 Insurance Payers 90
8 Segmentation of Global Market by Region 91
8.1 Geographic Market Overview 2019-2030 91
8.2 North America Market 2019-2030 by Country 95
8.2.1 Overview of North America Market 95
8.2.2 U.S. 99
8.2.3 Canada 103
8.2.4 Mexico 105
8.3 European Market 2019-2030 by Country 107
8.3.1 Overview of European Market 107
8.3.2 Germany 111
8.3.3 UK 113
8.3.4 France 115
8.3.5 Netherlands 117
8.3.6 Italy 119
8.3.7 Russia 121
8.3.8 Rest of European Market 123
8.4 Asia-Pacific Market 2019-2030 by Country 125
8.4.1 Overview of Asia-Pacific Market 125
8.4.2 Japan 129
8.4.3 China 132
8.4.4 Australia 134
8.4.5 India 136
8.4.6 South Korea 138
8.4.7 Rest of APAC Region 140
8.5 South America Market 2019-2030 by Country 142
8.5.1 Argentina 145
8.5.2 Brazil 147
8.5.3 Chile 149
8.5.4 Rest of South America Market 151
8.6 MEA Market 2019-2030 by Country 152
8.6.1 UAE 155
8.6.2 Saudi Arabia 157
8.6.3 Israel 159
8.6.4 Other National Markets 161
9 Competitive Landscape 162
9.1 Overview of Key Vendors 162
9.2 New Product Launch, Partnership, Investment, and M&A 166
9.3 Company Profiles 167
Actigraph LLC 167
Akili Interactive Labs 169
AliveCor Inc 170
Altoida Inc 171
Amgen Inc 172
Bayer AG 173
Biogen Inc 174
Cambridge Cognition Plc 175
Eli Lilly and Company 176
Evidation Health, Inc. 177
F. Hoffmann-La Roche Ltd 178
Fitbit Inc 179
GlaxoSmithKline Plc 180
Happify Health 181
Human API 182
IXICO Plc 183
Koninklijke Philips N.V. 184
Medical Care Corporation 185
Medopad Ltd 186
Mindstrong Health 187
Neurotrack Technology, Inc 188
Novartis International AG 189
Pfizer Inc. 190
Quanterix Corporation 191
Sanofi S.A. 192
The Takeda Pharmaceuticals Company Limited 193
Verily Life Sciences 194
Winterlight Labs Inc. 195
10 Investing in Global Market: Risk Assessment and Management 196
10.1 Risk Evaluation of Global Market 196
10.2 Critical Success Factors (CSFs) 199
Related Reports and Products 199